English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Oral Health Foundation urges inclusion of dental care in new DHSC–NHS England leadership
+ Pharmaceuticals
Patient Daily | Sep 19, 2025

UTHealth Houston receives $2 million grant for nonaddictive diabetic neuropathy therapy research
+ Pharmaceuticals
Patient Daily | Sep 18, 2025

UTHealth Houston awarded $27 million grant for national Alzheimer’s disease research network
+ Pharmaceuticals
Patient Daily | Sep 17, 2025

Baylor College of Medicine expert discusses updated flu vaccines ahead of upcoming season
+ Pharmaceuticals
Patient Daily | Sep 16, 2025

Baylor receives $5.9M grant for Houston Nutrition and Obesity Research Center
+ Pharmaceuticals
Patient Daily | Sep 16, 2025

Cleveland Clinic sponsors annual LUNG FORCE Walk in partnership with American Lung Association

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes